Rebound Therapeutics
Innovative single-use devices enhancing minimally invasive neurosurgical procedures with advanced access, imaging, and illumination
About Rebound Therapeutics
Rebound Therapeutics is a privately held medical device company specializing in the development of innovative single-use, disposable devices designed to improve the procedural and clinical outcomes of minimally invasive surgical procedures. The company's flagship products, the Surgiscope System and Evacuator, are tailored for a variety of minimally invasive neurosurgical applications. Rebound Therapeutics serves healthcare providers and surgical centers, primarily operating within the medical technology and neurosurgery markets. The business model focuses on the development and commercialization of advanced surgical tools that enhance precision, safety, and efficiency during operations. Revenue is generated through the sale of these specialized devices to medical institutions and practitioners. The company is continually exploring additional clinical applications for its technology to expand its market reach and impact.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Irvine, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Invus- WCWexford Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rebound Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rebound Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.